INSPECS Group Past Earnings Performance
Past criteria checks 0/6
INSPECS Group's earnings have been declining at an average annual rate of -37.3%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 37.1% per year.
Key information
-37.3%
Earnings growth rate
-94.0%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 37.1% |
| Return on equity | -1.0% |
| Net Margin | -0.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How INSPECS Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 203 | -1 | 101 | 0 |
| 30 Sep 23 | 205 | -1 | 102 | 0 |
| 30 Jun 23 | 202 | -1 | 101 | 0 |
| 31 Mar 23 | 204 | -4 | 102 | 0 |
| 31 Dec 22 | 201 | -6 | 100 | 0 |
| 30 Sep 22 | 207 | -5 | 102 | 0 |
| 30 Jun 22 | 204 | -4 | 100 | 0 |
| 31 Mar 22 | 192 | -4 | 91 | 0 |
| 31 Dec 21 | 182 | -4 | 84 | 0 |
| 30 Sep 21 | 149 | -4 | 67 | 0 |
| 30 Jun 21 | 113 | -4 | 49 | 0 |
| 31 Mar 21 | 74 | -5 | 33 | 0 |
| 31 Dec 20 | 35 | -7 | 17 | 0 |
| 30 Sep 20 | 37 | -6 | 17 | 0 |
| 30 Jun 20 | 38 | -5 | 16 | 0 |
| 31 Mar 20 | 44 | 0 | 16 | 0 |
| 31 Dec 19 | 46 | 5 | 15 | 0 |
| 30 Sep 19 | 50 | 6 | 15 | 0 |
| 30 Jun 19 | 48 | 6 | 14 | 0 |
| 31 Mar 19 | 45 | 4 | 13 | 0 |
| 31 Dec 18 | 45 | 3 | 13 | 0 |
| 31 Dec 17 | 36 | -2 | 14 | 0 |
| 31 Dec 16 | 18 | 1 | 6 | 0 |
Quality Earnings: 4GV is currently unprofitable.
Growing Profit Margin: 4GV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4GV is unprofitable, and losses have increased over the past 5 years at a rate of 37.3% per year.
Accelerating Growth: Unable to compare 4GV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4GV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: 4GV has a negative Return on Equity (-0.96%), as it is currently unprofitable.